Medpace Financial Statements From 2010 to 2026

MEDP Stock  USD 571.02  0.00  0.00%   
Analyzing historical trends in various income statement and balance sheet accounts from Medpace Holdings' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Medpace Holdings' valuation are summarized below:
Gross Profit
1.6 B
Profit Margin
0.1836
Market Capitalization
16.1 B
Enterprise Value Revenue
6.7497
Revenue
2.4 B
There are currently one hundred twenty fundamental ratios for Medpace Holdings that can be evaluated and compared over time across peers in the industry. Investors and active traders are advised to check Medpace Holdings' last-minute fundamental performance against the performance between 2010 and 2026 to make sure the trends are evolving in the right direction. As of 01/05/2026, Market Cap is likely to drop to about 4.1 B. In addition to that, Enterprise Value is likely to drop to about 4.2 B

Medpace Holdings Total Revenue

2.55 Billion

Check Medpace Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medpace Holdings' main balance sheet or income statement drivers, such as Depreciation And Amortization of 30.2 M, Interest Expense of 23.6 M or Selling General Administrative of 215.8 M, as well as many indicators such as Price To Sales Ratio of 3.27, Dividend Yield of 0.0 or PTB Ratio of 5.7. Medpace financial statements analysis is a perfect complement when working with Medpace Holdings Valuation or Volatility modules.
  
Build AI portfolio with Medpace Stock
Check out the analysis of Medpace Holdings Correlation against competitors.
To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.

Medpace Holdings Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding28.7 M28.8 M35.5 M
Slightly volatile
Total Assets1.4 B2.4 B1.3 B
Slightly volatile
Short and Long Term Debt Total169 M134.6 M270.2 M
Slightly volatile
Other Current Liabilities408.3 M388.9 M162.9 M
Slightly volatile
Total Current Liabilities1.3 B1.3 B482.2 M
Slightly volatile
Total Stockholder Equity677.5 M949.4 M588.8 M
Slightly volatile
Other Liabilities20 M21.4 M26.9 M
Slightly volatile
Property Plant And Equipment Net150.8 M290.1 M123.6 M
Slightly volatile
Current Deferred Revenue858 M817.2 M284.1 M
Slightly volatile
Accounts Payable23.1 M37.4 M18.6 M
Slightly volatile
Cash808.3 M769.9 M221.5 M
Slightly volatile
Non Current Assets TotalB1.2 B957.6 M
Slightly volatile
Non Currrent Assets Other13.1 M25.6 M11.2 M
Slightly volatile
Other Assets83.6 M79.6 M35.4 M
Slightly volatile
Long Term Debt68.2 M71.7 M230.6 M
Slightly volatile
Cash And Short Term Investments808.3 M769.9 M221.5 M
Slightly volatile
Net Receivables177.8 M340.9 M150.4 M
Slightly volatile
Good Will530.1 M596.2 M652.7 M
Slightly volatile
Common Stock Total Equity279.2 K278.1 K327.5 K
Pretty Stable
Short Term InvestmentsK6.3 K514.9 K
Slightly volatile
Liabilities And Stockholders Equity1.4 B2.4 B1.3 B
Slightly volatile
Non Current Liabilities Total178 M153.7 M295.6 M
Slightly volatile
Inventory0.860.9511.7 K
Slightly volatile
Other Current Assets76.5 M72.9 M32.6 M
Slightly volatile
Other Stockholder Equity719.1 M956.6 M619.8 M
Slightly volatile
Total Liabilities750.7 M1.5 B735.6 M
Slightly volatile
Deferred Long Term Liabilities1.2 M1.2 M2.7 M
Very volatile
Property Plant And Equipment Gross424 M403.8 M156.8 M
Slightly volatile
Short and Long Term Debt42.8 M45 M205.5 M
Slightly volatile
Total Current Assets1.2 B1.2 B415.7 M
Slightly volatile
Short Term Debt25.4 M26.8 M62.3 M
Slightly volatile
Intangible Assets29.4 M30.9 M120.6 M
Slightly volatile
Common Stock273.1 K275.4 K326.8 K
Pretty Stable
Property Plant Equipment74.3 M126.3 M69.4 M
Slightly volatile
Long Term Debt Total184.8 M93.8 M227.6 M
Slightly volatile
Capital Surpluse714.1 M886.4 M619.3 M
Slightly volatile
Capital Lease Obligations95.1 M145.2 M70 M
Slightly volatile
Non Current Liabilities Other61.2 M49.1 M48.8 M
Pretty Stable
Deferred Long Term Asset Charges321.5 K338.4 K626.5 K
Very volatile
Net Invested Capital570 M743 M711.1 M
Pretty Stable
Capital Stock269 K275.4 K338 K
Slightly volatile

Medpace Holdings Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization30.2 M26.3 M35.4 M
Slightly volatile
Interest Expense23.6 M22.5 M14 M
Pretty Stable
Selling General Administrative215.8 M205.5 M95.2 M
Slightly volatile
Selling And Marketing Expenses907.5 K1.7 M790.1 K
Slightly volatile
Total Revenue2.5 B2.4 B980 M
Slightly volatile
Gross Profit792.5 M754.8 M315.5 M
Slightly volatile
Other Operating ExpensesB1.9 B798.3 M
Slightly volatile
Operating Income539.6 M513.9 M182.9 M
Slightly volatile
EBIT539.6 M513.9 M181.7 M
Slightly volatile
EBITDA574.9 M547.5 M217.9 M
Slightly volatile
Cost Of Revenue1.8 B1.7 B664.5 M
Slightly volatile
Total Operating Expenses145.2 M240.9 M127.5 M
Slightly volatile
Tax Provision86.4 M82.3 M26 M
Slightly volatile
Interest Income1.3 M1.4 M12.4 M
Slightly volatile
Reconciled Depreciation22.6 M26.3 M35.3 M
Slightly volatile
Extraordinary Items85.5 K90 K1.4 M
Slightly volatile

Medpace Holdings Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation16 M29.3 M13.3 M
Slightly volatile
Free Cash Flow691 M658.1 M243.7 M
Slightly volatile
Begin Period Cash Flow296.4 M282.3 M118.3 M
Slightly volatile
Depreciation30.2 M26.3 M35.4 M
Slightly volatile
Capital Expenditures22.5 M42 M19.1 M
Slightly volatile
Total Cash From Operating Activities735.1 M700.1 M264 M
Slightly volatile
End Period Cash Flow808.3 M769.9 M214.6 M
Slightly volatile
Change To Operating Activities58.5 M55.7 M19.9 M
Slightly volatile
Change To Inventory79.9 M76.1 M28.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.274.394.0243
Slightly volatile
PTB Ratio5.711.216.0864
Slightly volatile
Days Sales Outstanding71.7459.069.2115
Slightly volatile
Book Value Per Share14.3224.017.0499
Slightly volatile
Free Cash Flow Yield0.06670.0640.0659
Slightly volatile
Operating Cash Flow Per Share18.5817.77.4523
Slightly volatile
Stock Based Compensation To Revenue0.02240.01390.0178
Very volatile
Capex To Depreciation0.621.120.6722
Slightly volatile
PB Ratio5.711.216.0864
Slightly volatile
EV To Sales3.474.174.2749
Pretty Stable
Free Cash Flow Per Share17.4716.646.8751
Slightly volatile
ROIC0.350.340.1589
Slightly volatile
Inventory Turnover66 K62.9 K38.6 K
Slightly volatile
Days Of Inventory On Hand0.00570.0061.0908
Slightly volatile
Payables Turnover23.1340.228.313
Slightly volatile
Sales General And Administrative To Revenue0.120.09740.1025
Slightly volatile
Capex To Revenue0.01850.01560.0213
Pretty Stable
Cash Per Share20.4419.466.2759
Slightly volatile
POCF Ratio13.0215.215.0621
Slightly volatile
Interest Coverage652621391
Slightly volatile
Capex To Operating Cash Flow0.0750.0540.082
Pretty Stable
PFCF Ratio14.4116.1716.5244
Slightly volatile
Days Payables Outstanding15.039.413.7128
Slightly volatile
EV To Operating Cash Flow14.214.4417.0942
Very volatile
EV To Free Cash Flow15.7515.3618.7985
Pretty Stable
Intangibles To Total Assets0.690.380.6662
Slightly volatile
Current Ratio0.911.070.886
Pretty Stable
Receivables Turnover4.546.45.3591
Slightly volatile
Graham Number83.6679.6836.6875
Slightly volatile
Shareholders Equity Per Share14.3224.017.0499
Slightly volatile
Debt To Equity0.20.210.5616
Slightly volatile
Capex Per Share1.121.060.5779
Slightly volatile
Revenue Per Share64.3861.3227.7827
Slightly volatile
Interest Debt Per Share6.495.558.6651
Slightly volatile
Debt To Assets0.07780.08180.2214
Slightly volatile
Enterprise Value Over EBITDA16.0818.4618.1801
Slightly volatile
Short Term Coverage Ratios28.5630.06523
Slightly volatile
Operating Cycle72.5659.070.3481
Slightly volatile
Price Book Value Ratio5.711.216.0864
Slightly volatile
Days Of Payables Outstanding15.039.413.7128
Slightly volatile
Price To Operating Cash Flows Ratio13.0215.215.0621
Slightly volatile
Price To Free Cash Flows Ratio14.4116.1716.5244
Slightly volatile
Operating Profit Margin0.130.190.1665
Very volatile
Company Equity Multiplier1.772.292.3099
Pretty Stable
Long Term Debt To Capitalization0.130.140.2835
Slightly volatile
Total Debt To Capitalization0.260.180.3114
Slightly volatile
Return On Capital Employed0.420.40.1884
Slightly volatile
Debt Equity Ratio0.20.210.5616
Slightly volatile
Ebit Per Revenue0.130.190.1665
Very volatile
Quick Ratio0.91.070.8816
Pretty Stable
Dividend Paid And Capex Coverage Ratio12.9519.1613.9956
Slightly volatile
Net Income Per E B T0.650.760.7644
Slightly volatile
Cash Ratio0.570.550.38
Pretty Stable
Cash Conversion Cycle57.5349.656.6353
Slightly volatile
Operating Cash Flow Sales Ratio0.280.330.2787
Slightly volatile
Days Of Inventory Outstanding0.00570.0061.0908
Slightly volatile
Days Of Sales Outstanding71.7459.069.2115
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.01.080.9303
Pretty Stable
Cash Flow Coverage Ratios3.853.661.7273
Slightly volatile
Price To Book Ratio5.711.216.0864
Slightly volatile
Fixed Asset Turnover8.99.618.1173
Very volatile
Capital Expenditure Coverage Ratio12.9519.1613.9956
Slightly volatile
Price Cash Flow Ratio13.0215.215.0621
Slightly volatile
Enterprise Value Multiple16.0818.4618.1801
Slightly volatile
Debt Ratio0.07780.08180.2214
Slightly volatile
Cash Flow To Debt Ratio3.853.661.7273
Slightly volatile
Price Sales Ratio3.274.394.0243
Slightly volatile
Asset Turnover0.550.90.5931
Slightly volatile
Gross Profit Margin0.390.360.3733
Slightly volatile
Price Fair Value5.711.216.0864
Slightly volatile

Medpace Holdings Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.1 B6.2 B5.3 B
Slightly volatile
Enterprise Value4.2 B6.3 B5.3 B
Slightly volatile

Medpace Fundamental Market Drivers

Forward Price Earnings35.8423
Cash And Short Term Investments669.4 M

Medpace Upcoming Events

12th of February 2024
Upcoming Quarterly Report
View
22nd of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
12th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Medpace Holdings Financial Statements

Medpace Holdings shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Medpace Holdings investors may analyze each financial statement separately, they are all interrelated. The changes in Medpace Holdings' assets and liabilities, for example, are also reflected in the revenues and expenses on on Medpace Holdings' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue817.2 M858 M
Total Revenue2.4 B2.5 B
Cost Of Revenue1.7 B1.8 B
Stock Based Compensation To Revenue 0.01  0.02 
Sales General And Administrative To Revenue 0.10  0.12 
Capex To Revenue 0.02  0.02 
Revenue Per Share 61.32  64.38 
Ebit Per Revenue 0.19  0.13 

Pair Trading with Medpace Holdings

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medpace Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medpace Holdings will appreciate offsetting losses from the drop in the long position's value.

Moving together with Medpace Stock

  0.7A Agilent TechnologiesPairCorr
  0.78TMO Thermo Fisher ScientificPairCorr

Moving against Medpace Stock

  0.67ICLR ICON PLCPairCorr
  0.44TEM Tempus AI ClassPairCorr
  0.44PRTC PureTech Health plcPairCorr
The ability to find closely correlated positions to Medpace Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medpace Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medpace Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medpace Holdings to buy it.
The correlation of Medpace Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medpace Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medpace Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medpace Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Medpace Stock Analysis

When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.